Therapeutic Asset Ratings

6,302 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Fruquintinib Head And Neck Squamous Cell Carcinoma	Immunitas Therapeutics	P1/2	CC (46)
Fruquintinib Small Intestine Cancer	Immunitas Therapeutics	P1/2	CC (46)
gc012f Plasma Cell Myeloma	Gracell Biotechnologies (Shanghai) Co., Ltd.	P1/2	CC (46)
Golcadomide Peripheral T-Cell Lymphoma, Not Otherwise Specified	The Lymphoma Academic Research Organisation	P1/2	CC (46)
hlx301 Metastatic Neoplasm	Shanghai Henlius Biotech	P1/2	CC (46)
Iberdomide B-Cell Non-Hodgkin Lymphoma	Celgene	P1/2	CC (46)
Ibrutinib Refractory Hematologic Cancer	Curis, Inc.	P1/2	CC (46)
Ifebemtinib Neoplasm	InxMed (Shanghai) Co., Ltd.	P1/2	CC (46)
IM19 CAR-T cells Leukemia	Beijing Immunochina Medical Science & Technology Co., Ltd.	P1/2	CC (46)
Immunoglobulin G1, Anti-(Human Interleukin-1 Receptor Accessory Protein) (Human-Mus Musculus Monoclonal Can04 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal Can04 .Kappa.-Chain, Dimer Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1/2	CC (46)
Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide Female Reproductive Organ Cancer	Sichuan Baili Pharmaceutical Co., Ltd.	P1/2	CC (46)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Met (Met Proto-Oncogene, Hepatocyte Growth Factor (Hgf) Receptor, Hgfr, Scatter Factor (Sf) Receptor, Hgf/Sf Receptor, Receptor Tyrosine-Protein Kinase C-Met, Papillary Renal Cell Carcinoma 2, Rccp2)] And Anti-[Homo Sapiens Egfr (Epidermal Growth Factor Receptor, Receptor Tyrosine-Protein Kinase Erbb-1, Erbb1, Her1, Her-1, Erbb)], Homo Sapiens Monoclonal Antibody, Bispecific Gastric Cancer	Merus B.V.	P1/2	CC (46)
Immunoglobulin G4 [237-Proline,242-Proline,243-Valine,244-Alanine,De-245-Glycine], Anti-(Human Mucin-16) (Human Monoclonal Regn5668 ?4-Chain), Disulfide With Human Monoclonal Regn5668 ?-Chain, (235?228?),(238?231?)-Bis(Disulfide) With Immunoglobulin G4 [230-Proline,235-Proline,236-Valine,237-Alanine,De-238-Glycine,436-Arginine,437-Phenylalanine,446-Proline] Anti-(Human Cd28 Antigen) (Human Monoclonal Regn5668 ?4-Chain) Disulfide With Human Monoclonal Regn5668 ?-Chain Ovarian Cancer	Regeneron Pharmaceuticals	P1/2	CC (46)
Immunoglobulin G4-Kappa, Anti-[Homo Sapiens Cd47 (Cd47 Molecule, Integrin Associated Protein, Iap, Mer6, Oa3)] And Anti-[Homo Sapiens Cd274 (Programmed Cell Death 1 Ligand 1, Pdl1, Pd-L1, B7 Homolog 1, B7H1, B7-H1, Pdcd1Lg1)], Humanized Monoclonal Antibody, Bispecific, Bivalent Myelodysplastic Syndrome	Mabwell (Shanghai) Bioscience Co., Ltd.	P1/2	CC (46)
Inavolisib Estrogen-Receptor Positive Breast Cancer	Hoffmann-La Roche	P1/2	CC (46)
Inobrodib Non-Hodgkin Lymphoma	CellCentric Ltd.	P1/2	CC (46)
Ivonescimab Glioblastoma	M.D. Anderson Cancer Center	P1/2	CC (46)
Lacutoclax Follicular Lymphoma	Guangzhou Lupeng Pharmaceutical Company LTD.	P1/2	CC (46)
Lacutoclax Waldenstrom Macroglobulinemia	Guangzhou Lupeng Pharmaceutical Company LTD.	P1/2	CC (46)
Lenalidomide Composite Lymphoma	M.D. Anderson Cancer Center	P1/2	CC (46)
Mezigdomide Mixed Phenotype Acute Leukemia	Memorial Sloan Kettering Cancer Center	P1/2	CC (46)
Midomafetamine Schizophrenia	Anya Bershad, MD, PhD	P1/2	CC (46)
mk-4830 Esophageal Squamous Cell Carcinoma	Merck Sharp & Dohme LLC	P1/2	CC (46)
Monoclonal Antibody Neo-201 Non-Small Cell Lung Carcinoma	Precision Biologics, Inc	P1/2	CC (46)
Muzastotug Neoplasm	Sanofi	P1/2	CC (46)

Showing 3226 to 3250 of 6,302 assets

PreviousPage 130 of 253Next